African sleeping sickness.

Checchi, Francesco; Barrett, Michael P · BMJ · 2008

editorial · Level V

Where this comes from

Abstract

Eflornithine should be the drug of choice for stage 2 disease, but resistance must be monitored

Medical subject headings